- 英文名称3-Amino-4,4,4-Trifluorobutyric Acid
- 中文名称3-氨基-4,4,4-三氟丁酸
- IUPAC名称3-amino-4,4,4-trifluorobutanoic acid
- 其它别名4,4,4-Trifluoro-Beta-Homoalanine; (3R)-3-Ammonio-4,4,4-Trifluorobutanoate; Dl-3-Amino-4,4,4-Trifluorobutyric Acid; 3-Amino-4,4,4-Trifluorobutanoic Acid; 3-Amino-4,4,4-Trifluorobutyric Acid; 4,4,4-Trifluoro-β-Homoalanine; 3-Amino-4,4,4-Trifluorobutyric Acid ; 3-Amino-4,4,4-Trifluorobutyricacid
- CAS编号584-20-3
- MFCD编号:MFCD00041413
- EINECS号:634-669-0
- 分子式:C4H6F3NO2分子量:157.09
- 产品CID: 1558972
- 产品分类有机原料→分子砌块→脂肪链类化合物
相似化合物
151871-99-7 1310680-31-9 91291-66-6欧盟法规
ECHA物质C&L通报上下游产品
CAS号406-94-0 (E)-4,4,4-三氟丁-2-烯酸 | CAS号150618-36-3 methyl 3-(benzy... | CAS号748746-28-3 3-氨基-4,4,4-三氟丁酸甲酯 | CAS号88968-80-3 trimethylsilyl ... | CAS号88968-81-4 4-(trifluoromet...📜Methyl 3-(Benzylideneamino)-4,4,4-Trifluorobutyrate置于盐酸体系中,化学反应 6.0H,反应生成 3-氨基-4,4,4-三氟丁酸
参考文献:Transamination Of Fluorinated β-Keto Carboxylic Esters. A Biomimetic Approach To β-Polyfluoroalkyl-β-Amino Acids.
标题:Transamination Of Fluorinated β-Keto Carboxylic Esters. A Biomimetic Approach To β-Polyfluoroalkyl-β-Amino Acids.
摘要:The Base-Catalyzed Isomerization Of N-Benzylimines (Or Enamines) Of Beta-Polyfluoroalkyl-Beta-Ketocarboxylic Esters Cleanly Affords The N-Benzylidene Derivatives Of Beta-Polyfluoro-Beta-Aminocarboxylic Esters Which Are Hydrolyzed To Corresponding Amino Acids In High Overall Yields.
DOI:10.1016/s0040-4039(00)73652-5
海关参考信息
- 2905121000-正丙醇
2905130000-正丁醇
2912110000-甲醛
2912120000-乙醛 - 💡 提示:海关信息按照顺序优先匹配,如需确认的海关信息,请参考相关资料。
- 详情请参考:📖 海关编码查询和海关进出口税则
专利信息
专利号:US-6051704-A
优先权日:1996-07-22
标题:Synthesis of macrocyclic tetraamido-N ligands
发明人:GORDON-WYLIE SCOTT W; COLLINS TERRENCE J
权利人:UNIV CARNEGIE MELLON
摘要:New synthetic methods for the preparation of macrocyclic amido-N donor ligands are provided. The primary method of the present invention involves in general only two synthetic steps. In the first step, an α or β amino carboxylic acid is allowed to react with an optimal (approximately stoichiometric) amount of an activated malonate or oxalate derivative with mild heating. Upon completion of the double coupling reaction, hydrolysis of the reaction mixture yields a diamide containing intermediate (a macro linker). In the second step, stoichiometric amounts of a diamine, preferably an orthophenylene diamine, are added to the macro linker intermediate in the presence of a coupling agent and heat. This second double coupling reaction, is allowed to proceed for a period of time sufficient to produce a macrocyclic tetraamido compound. The substituent groups on the α or β amino carboxylic acid, the malonate, and the aryl diamine may all be selectively varied so that the resulting tetraamido macrocycle can be tailored to specific desired end uses. The macrocyclic tetraamide ligand may then be complexed with a metal, such as a transition metal, and preferably the middle and later transition metals, to form a robust chelate complex suitable for catalyzing oxidation reactions.
专利号:US-2022243244-A1
优先权日:2019-10-10
标 题 :Compositions and methods for in vivo synthesis of unnatural polypeptides
发明人:ROMESBERG FLOYD E; FISCHER EMIL C; HASHIMOTO KOJI; FELDMAN AARON W; DIEN VIVIAN T; ZHANG YORKE
权利人:SCRIPPS RESEARCH INST
摘要:Disclosed herein are compositions, methods, and kits for a cell incorporating unnatural amino acids into an unnatural polypeptide. Also disclosed herein are compositions, methods, and kits for increasing activity and yield of the unnatural polypeptide synthesized by the cell.
专利号:US-2023037284-A9
优先权日:2018-11-30
标题:Combination therapy of peptidomimetic macrocycles
发明人:GUERLAVAIS VINCENT; ANNIS DAVID ALLEN
权利人:AILERON THERAPEUTICS INC
摘要:The present disclosure describes the synthesis of peptidomimetic macrocycles and methods of using peptidomimetic macrocycles to treat a condition. The present disclosure also describes methods of using peptidomimetic macrocycles in combination with at least one additional pharmaceutically-active agent for the treatment of a condition, for example, cancer.
专利号:US-2025084410-A1
优先权日:2015-01-12
标 题:Incorporation of unnatural nucleotides and methods thereof
发明人:PTACIN JEROD; MALYSHEV DENIS A; CAFFARO CAROLINA E
权利人:SYNTHORX INC
摘要:Disclosed herein are methods, compositions and kits for the synthesis of proteins which comprises unnatural amino acids that utilize a mutant tRNA.
专利号:US-7060818-B2
优先权日:2003-02-21
标题:Synthesis of macrocyclic tetraamido compounds and new metal insertion process
发明人:HORWITZ COLIN P; GHOSH ANINDYA
权利人:UNIV CARNEGIE MELLON
摘要:An improved method of synthesizing a macrocyclic tetraamido compound includes protecting the amino portion of an amino carboxylic acid to form a protected amino carboxylic acid; exposing the protected amino carboxylic acid to a first solvent, preferably a hydrocarbon solvent, such as toluene or 1,2-dichloroethane, dichloromethane, dibromomethane and 1,2-dibromoethane. The carboxylic acid portion of the protected amino carboxylic acid is then converted to an activated carboxylic acid by one of esterification or acid halide formation, to form a protected amino activated carboxylic acid derivative. The protected amino activated carboxylic acid derivative is reacted with a diamine in the presence of a second solvent, such as THF or ,2-dichloroethane, dichloromethane, dibromomethane and 1,2-dibromoethane, to form a protected diamide diamine intermediate. Following deprotection, the diamide diamine intermediate is reacted with an activated diacid, such as an activated malonate, oxalate or succinate derivative to form the macrocyclic tetraamido compound. The macrocyclic tetraamido compound may further be complexed with a transition metal.
专利号:US-2018371021-A1
优先权日:2017-05-11
标 题 :Peptidomimetic macrocycles and uses thereof
发明人:AIVADO MANUEL; GUERLAVAIS VINCENT; OLSON KAREN
权利人:AILERON THERAPEUTICS INC
摘要:The present disclosure describes the synthesis of peptidomimetic macrocycles and methods of using peptidomimetic macrocycles to treat a condition. The present disclosure also describes methods of using peptidomimetic macrocycles in combination with at least one additional pharmaceutically-active agent for the treatment of a condition, for example, cancer.